HALOZYME THERAPEUTICS INC (HALO)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for HALO
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HALO | President and Chief Executive Officer | [] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| DGX | [] | ["Quality and Compliance Committee"] | 2022 |
Biography sourced from the proxy statement filing.
President and Chief Executive Officer. Dr. Torley has served as Halozyme's CEO since January 2014, over which time the Company has experienced significant growth, with total revenues increasing from $55 million in 2013 to nearly $1.40 billion in 2025 (+2445%) and market capitalization increasing from $1.72 billion as of December 31, 2013 to $7.93 billion as of December 31, 2025 (+361%).